NIRVF (Nirvana Life Sciences) Other Stockholders Equity: $0.42 Mil (As of Jan. 2026)


What is Nirvana Life Sciences Other Stockholders Equity?

Nirvana Life Sciences NIRVF Other Stockholders Equity is $0.42 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's Other Stockholders Equity for the quarter that ended in Jan. 2026 was $0.42 Mil.

Nirvana Life Sciences's quarterly Other Stockholders Equity declined from Jul. 2025 ($0.42 Mil) to Oct. 2025 ($0.41 Mil) but then increased from Oct. 2025 ($0.41 Mil) to Jan. 2026 ($0.42 Mil).

Nirvana Life Sciences's annual Other Stockholders Equity increased from Apr. 2023 ($0.32 Mil) to Apr. 2024 ($0.41 Mil) and increased from Apr. 2024 ($0.41 Mil) to Apr. 2025 ($0.41 Mil).

Nirvana Life Sciences Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Other Stockholders Equity Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Other Stockholders Equity
Get a 7-Day Free Trial 0.15 0.09 0.32 0.41 0.41

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.41 0.42 0.41 0.42

Nirvana Life Sciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.42 Mil mean?
Nirvana Life Sciences (NIRVF) has a Other Stockholders Equity of $0.42 Mil as of Jan. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Other Stockholders Equity too high?
Nirvana Life Sciences' current Other Stockholders Equity is $0.42 Mil.
How does Nirvana Life Sciences' Other Stockholders Equity compare to VRTX and REGN?
Nirvana Life Sciences' Other Stockholders Equity of $0.42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Other Stockholders Equity is $0.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Other Stockholders Equity of $0.42 Mil. The current Other Stockholders Equity is $0.42 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Other Stockholders Equity is $0.42 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.